1. Home
  2. ABSI vs ADNT Comparison

ABSI vs ADNT Comparison

Compare ABSI & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Absci Corporation

ABSI

Absci Corporation

N/A

Current Price

$8.40

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo Adient plc

ADNT

Adient plc

N/A

Current Price

$15.17

Market Cap

1.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
ABSI
ADNT
Founded
2011
2016
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
ABSI
ADNT
Price
$8.40
$15.17
Analyst Decision
Strong Buy
Buy
Analyst Count
12
12
Target Price
$15.09
★ $25.09
AVG Volume (30 Days)
★ 4.2M
1.2M
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
10.64
★ 93.51
EPS
N/A
★ N/A
Revenue
$4,534,000.00
★ $17,439,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$37.25
$2.26
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.56
52 Week Low
$2.24
$14.93
52 Week High
$12.54
$27.32

Technical Indicators

Market Signals
Indicator
ABSI
ADNT
Relative Strength Index (RSI) 43.96 32.68
Support Level $7.79 N/A
Resistance Level $11.94 $18.36
Average True Range (ATR) 1.03 0.86
MACD -0.30 -0.14
Stochastic Oscillator 24.61 11.53

Price Performance

Historical Comparison
ABSI
ADNT

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

About ADNT Adient plc

Adient began trading in October 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market, including unconsolidated joint-venture business. Its share in China is around 20%, down from about 45% following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025, and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. In fiscal 2026 (ended September), consolidated revenue, excluding joint-venture sales, was $15.2 billion.

Share on Social Networks: